Filing Flows › Utah Medical Products (UTMD) › R&D spending
Utah Medical Products (UTMD) R&D spending by quarter
Utah Medical Products' R&D spending was $154K in Q2 2026 (second quarter 2026), 0% from Q1 2026. Over the last 7 quarters it ranged from $121K (Q4 2024) to $212K (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $154K | 0% | +14% |
| Q1 2026 | $154K | -27% | 0% |
| Q4 2025 | $212K | +27% | +75% |
| Q3 2025 | $167K | +24% | — |
| Q2 2025 | $135K | -12% | — |
| Q1 2025 | $154K | +27% | — |
| Q4 2024 | $121K | — | — |
Q2 2026 at a glance
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Utah Medical Products' R&D spending?
Utah Medical Products' R&D spending was $154K in Q2 2026 (second quarter 2026), 0% from Q1 2026.
How has Utah Medical Products' R&D spending changed?
Over the last 7 quarters it ranged from $121K (Q4 2024) to $212K (Q4 2025).